March 11, 2026 a 04:38 pm
MO: Analysts Ratings - Altria Group, Inc.
Altria Group, Inc. has been a stable player in the tobacco industry for decades, with its iconic Marlboro brand capturing a significant market share. Despite challenges from regulatory environments and shifting consumer preferences, the company's performance remains resilient. Analysts offer cautious optimism, balancing the company's robust dividend payouts against ongoing industry headwinds.
Historical Stock Grades
The latest analyst recommendations reflect a mature view of Altria's market position. While there are no Strong Buy ratings, most analysts are inclined towards maintaining Buy and Hold positions, indicating a consistent, albeit measured, confidence in the company's future performance.
| Rating | Count | Score |
|---|---|---|
| Strong Buy | 0 | |
| Buy | 5 | |
| Hold | 7 | |
| Sell | 1 | |
| Strong Sell | 1 |
Sentiment Development
Over recent months, the sentiment has stabilized around a combination of buy and hold recommendations. The total number of ratings remains consistent, though there's a notable decline in Strong Buy recommendations, indicating growing caution. Observation shows:
- Stable number of Buy ratings in recent months.
- Gradual increase in Hold ratings, suggesting retention strategy over aggressive buying.
- Sell and Strong Sell ratings remain minimal, reinforcing a generally neutral to positive sentiment.
Percentage Trends
The distribution of ratings over the past months displays a discernible shift towards conservatism. Here's a breakdown of changes:
- Strong Buy ratings reduced to 0% in recent analysis, signaling heightened cautiousness.
- Buy and Hold ratings consistently account for the majority, indicating a preference for stability.
- Sell ratings remain low, showing confidence in Altria's ongoing operations.
In the last 6–12 months, the ratings pivoted slightly from Strong Buys to more conservative Holds, implying analyst expectations for moderate growth tempered by external challenges.
Latest Analyst Recommendations
A review of the latest recommendations underscores stability, as most recent analyses show maintenance of current ratings:
| Date | New Recommendation | Last Recommendation | Publisher |
|---|---|---|---|
| 2026-03-09 | Buy | Buy | UBS |
| 2026-02-23 | Underweight | Underweight | Barclays |
| 2026-02-09 | Neutral | Neutral | Citigroup |
| 2026-01-30 | Buy | Buy | Stifel |
| 2026-01-26 | Buy | Buy | UBS |
Analyst Recommendations with Change of Opinion
Examining changes in opinion provides insights into evolving analyst perspectives:
| Date | New Recommendation | Last Recommendation | Publisher |
|---|---|---|---|
| 2026-01-09 | Buy | Neutral | UBS |
| 2025-07-02 | Neutral | Sell | UBS |
| 2024-12-06 | Buy | Neutral | B of A Securities |
| 2022-11-10 | Sell | Neutral | UBS |
| 2022-11-09 | Sell | Neutral | UBS |
Interpretation
Altria's stability in the tobacco sector is reflected in the analyst sentiments, which lean towards cautious optimism. The presence of several Hold ratings suggests that while the company's dividends are attractive, growth expectations remain moderated by regulatory uncertainties. The oscillation between Neutral and Buy recommendations further emphasizes this cautious stance. Analysis reveals no dramatic shifts, yet a steady confidence in Altria's financial health and market position persists.
Conclusion
Altria Group, Inc. continues to display resilience in an evolving industry landscape. Analysts exhibit balanced confidence, acknowledging Altria's strong dividend yield against the backdrop of stagnant growth trends. Despite challenges, the company's market position remains robust, although investor caution is evident in the decreasing number of Strong Buy ratings. The outlook suggests continued focus on dividend stability and conservative growth expectations.